Matches in SemOpenAlex for { <https://semopenalex.org/work/W4220989894> ?p ?o ?g. }
- W4220989894 abstract "Abstract Introduction Diarrhea-predominant irritable bowel syndrome (IBS-D) is a bowel disease with a high incidence. It significantly reduces the quality of life of patients and affects the patient's daily activities and mental health. No specific therapeutic medications for IBS-D have been found. Published clinical trials suggest that Chinese herbal formula Tongxie Yaofang (TXYF) for IBS-D may be effective. However, high-quality clinical evidence supporting its use in IBS-D is still lacking. This trial aims to evaluate the therapeutic effects and safety of TXYF for IBS-D in adults. Methods/design A randomized, multiple-blind, placebo-controlled trial will be conducted. It will consist of an 8-week intervention followed by a 3-month follow-up period. The target sample size is 96 IBS-D patients aged 18 to 65 years. The eligible participants will be randomly allocated to either TXYF or placebo group in a ratio of 1:1. Participants in the experimental group will take TXYF granules, while participants in the control group will be given TXYF placebo granules. The primary outcome will be the degree of IBS symptom severity measured using the scale of IBS symptom severity score. The secondary outcomes include: (a) stool frequency, and (b) stool consistency measured using the Bristol stool scale, (c) quality of life measured using the scale of IBS-quality of life, (d) anxiety measured using the self-rating anxiety scale, (e) depression measured by the self-rating depression scale, and (f) the safety of using TXYF and placebo. Safety monitoring and assessment will be undertaken throughout treatment. Discussion Chinese herbal formula TXYF consists of four Chinese herbs: Atractylodes macrocephala Koidz. , Paeonia lactiflora Pall . , Citrus × aurantium L . , and Radix saposhnikoviae . It has been used for diarrhea for hundreds of years and may have a potential benefit in treating adults with IBS-D, but due to lack of high-quality evidence, we designed a randomized, multiple-blind, placebo-controlled trial to evaluate its therapeutic effects and safety. This trial will provide important data to guide the clinical practice of TXYF for the treatment of IBS-D in adults. Trial registration ISRCTN registry ISRCTN12453166 . Registered on 23 March 2021." @default.
- W4220989894 created "2022-04-03" @default.
- W4220989894 creator A5000947189 @default.
- W4220989894 creator A5023167962 @default.
- W4220989894 creator A5039910711 @default.
- W4220989894 creator A5043311841 @default.
- W4220989894 creator A5062355675 @default.
- W4220989894 creator A5072001815 @default.
- W4220989894 creator A5075042346 @default.
- W4220989894 creator A5077810337 @default.
- W4220989894 date "2022-03-21" @default.
- W4220989894 modified "2023-10-04" @default.
- W4220989894 title "Chinese herbal formula Tongxie Yaofang for diarrhea-predominant irritable bowel syndrome: study protocol for a randomized, multiple-blind, placebo-controlled trial" @default.
- W4220989894 cites W1532990492 @default.
- W4220989894 cites W1683418430 @default.
- W4220989894 cites W1917184534 @default.
- W4220989894 cites W1966160259 @default.
- W4220989894 cites W1969547130 @default.
- W4220989894 cites W2004111306 @default.
- W4220989894 cites W2025189539 @default.
- W4220989894 cites W2026224416 @default.
- W4220989894 cites W2046549547 @default.
- W4220989894 cites W2047829692 @default.
- W4220989894 cites W2052872631 @default.
- W4220989894 cites W2056304431 @default.
- W4220989894 cites W2075209865 @default.
- W4220989894 cites W2138706910 @default.
- W4220989894 cites W2146147731 @default.
- W4220989894 cites W2146589073 @default.
- W4220989894 cites W2166102321 @default.
- W4220989894 cites W2170332928 @default.
- W4220989894 cites W2171811563 @default.
- W4220989894 cites W2318140663 @default.
- W4220989894 cites W2325108915 @default.
- W4220989894 cites W2494623578 @default.
- W4220989894 cites W2592409001 @default.
- W4220989894 cites W2745239398 @default.
- W4220989894 cites W2763056653 @default.
- W4220989894 cites W2805556088 @default.
- W4220989894 cites W3042758557 @default.
- W4220989894 cites W4211073917 @default.
- W4220989894 doi "https://doi.org/10.1186/s13063-022-06142-x" @default.
- W4220989894 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/35313933" @default.
- W4220989894 hasPublicationYear "2022" @default.
- W4220989894 type Work @default.
- W4220989894 citedByCount "3" @default.
- W4220989894 countsByYear W42209898942022 @default.
- W4220989894 countsByYear W42209898942023 @default.
- W4220989894 crossrefType "journal-article" @default.
- W4220989894 hasAuthorship W4220989894A5000947189 @default.
- W4220989894 hasAuthorship W4220989894A5023167962 @default.
- W4220989894 hasAuthorship W4220989894A5039910711 @default.
- W4220989894 hasAuthorship W4220989894A5043311841 @default.
- W4220989894 hasAuthorship W4220989894A5062355675 @default.
- W4220989894 hasAuthorship W4220989894A5072001815 @default.
- W4220989894 hasAuthorship W4220989894A5075042346 @default.
- W4220989894 hasAuthorship W4220989894A5077810337 @default.
- W4220989894 hasBestOaLocation W42209898941 @default.
- W4220989894 hasConcept C118552586 @default.
- W4220989894 hasConcept C126322002 @default.
- W4220989894 hasConcept C138496976 @default.
- W4220989894 hasConcept C139719470 @default.
- W4220989894 hasConcept C142724271 @default.
- W4220989894 hasConcept C15744967 @default.
- W4220989894 hasConcept C159110408 @default.
- W4220989894 hasConcept C162324750 @default.
- W4220989894 hasConcept C168563851 @default.
- W4220989894 hasConcept C1862650 @default.
- W4220989894 hasConcept C197934379 @default.
- W4220989894 hasConcept C204787440 @default.
- W4220989894 hasConcept C27081682 @default.
- W4220989894 hasConcept C2776867660 @default.
- W4220989894 hasConcept C2778271842 @default.
- W4220989894 hasConcept C2779802037 @default.
- W4220989894 hasConcept C2779951463 @default.
- W4220989894 hasConcept C535046627 @default.
- W4220989894 hasConcept C558461103 @default.
- W4220989894 hasConcept C71924100 @default.
- W4220989894 hasConcept C83849319 @default.
- W4220989894 hasConceptScore W4220989894C118552586 @default.
- W4220989894 hasConceptScore W4220989894C126322002 @default.
- W4220989894 hasConceptScore W4220989894C138496976 @default.
- W4220989894 hasConceptScore W4220989894C139719470 @default.
- W4220989894 hasConceptScore W4220989894C142724271 @default.
- W4220989894 hasConceptScore W4220989894C15744967 @default.
- W4220989894 hasConceptScore W4220989894C159110408 @default.
- W4220989894 hasConceptScore W4220989894C162324750 @default.
- W4220989894 hasConceptScore W4220989894C168563851 @default.
- W4220989894 hasConceptScore W4220989894C1862650 @default.
- W4220989894 hasConceptScore W4220989894C197934379 @default.
- W4220989894 hasConceptScore W4220989894C204787440 @default.
- W4220989894 hasConceptScore W4220989894C27081682 @default.
- W4220989894 hasConceptScore W4220989894C2776867660 @default.
- W4220989894 hasConceptScore W4220989894C2778271842 @default.
- W4220989894 hasConceptScore W4220989894C2779802037 @default.
- W4220989894 hasConceptScore W4220989894C2779951463 @default.
- W4220989894 hasConceptScore W4220989894C535046627 @default.
- W4220989894 hasConceptScore W4220989894C558461103 @default.
- W4220989894 hasConceptScore W4220989894C71924100 @default.
- W4220989894 hasConceptScore W4220989894C83849319 @default.